.jpg?format=webp&width=780)
A study revealed significant differences between COVID-19-related ARDS and non-COVID ARDS. Researchers conducted a comparative study in the ICU over two years, analyzing clinical, echocardiographic, and lab data from 140 ARDS patients. The COVID-19 group, mainly younger males with higher BMI, faced more severe outcomes, including organ dysfunction and higher SOFA scores. Despite greater severity, they had lower comorbidities. This insight could reshape ARDS management.
Like
Save
Share